THE DEVLOPMENT OF INSULIN
Eli Lilly and the Story of Insulin:
Introduction
The discovery and commercialization of insulin stand as one of the most important milestones in medical history. Before insulin, diabetes was often a death sentence. The collaboration between Canadian researchers and Eli Lilly & Company changed that forever, making insulin widely available and saving millions of lives.
The Early Days of Insulin
In 1921, Canadian scientists Frederick Banting and Charles Best discovered insulin.
Eli Lilly partnered with them to mass-produce insulin, becoming the first pharmaceutical company to do so in 1923.
The initial product, Iletin, was derived from animal pancreases (cattle and pigs). While effective, it had limitations in purity and consistency.
Advances in Biotechnology
By the late 20th century, Eli Lilly pioneered the use of recombinant DNA technology to produce biosynthetic human insulin.
This breakthrough eliminated the need for animal sources, reduced allergic reactions, and improved consistency.
Later, Lilly introduced human insulin analogs, engineered to act faster or last longer than natural insulin, offering better control for patients.
Impact on Human Welfare
Medical Revolution: Insulin transformed diabetes from a fatal disease into a manageable chronic condition.
Biotechnology Milestone: The recombinant DNA insulin was one of the first major successes of genetic engineering in medicine.
Global Reach: Eli Lilly’s production ensured insulin availability worldwide, setting the stage for modern diabetes care.
Challenges and Future Directions
Despite scientific progress, insulin affordability remains a global issue.
Ongoing research focuses on oral insulin delivery, smart insulin systems, and cell-based therapies to further improve patient outcomes.
Biotechnology continues to expand possibilities, but equitable access remains a critical challenge.
Conclusion
The story of Eli Lilly and insulin is not just about a drug—it is about the intersection of biology, biotechnology, and human welfare. From animal extracts to recombinant DNA, insulin’s journey reflects the power of science to transform lives. As research advances, the legacy of insulin reminds us that innovation must always serve humanity.
Comments
Post a Comment